
Loading, please wait...

Loading, please wait...

Identification of enzyme functions is a cornerstone of understanding complex cellular processes. Researchers have recently introduced EC-LMGraph, a state-of-the-art framework for enzyme function prediction AI. This innovative tool utilizes protein language models and graph convolutional networks to predict Enzyme Commission (EC) numbers from both protein sequence features and structures. Consequently, it represents a significant leap forward in computational biology and precision medicine.
The model employs advanced saliency mapping to score specific residues based on their functional importance. This allows for the precise pinpointing of catalytic sites within a protein. Specifically, EC-LMGraph achieved an average F1 score of 0.77 for 3rd-level and 0.76 for 4th-level EC number predictions. Moreover, it consistently outperformed existing sequence-only algorithms and frameworks that incorporate structural data. These metrics suggest a high degree of reliability for researchers studying unannotated proteomes.
Researchers benchmarked the framework against a specific set of Parkinson's disease-related proteins to test its clinical relevance. Notably, EC-LMGraph showed a much stronger emphasis on identifying catalytic sites compared to the current state-of-the-art algorithm, DeepFRI. Furthermore, the system integrates seamlessly with AlphaFold2. This integration allowed the framework to determine the 3rd-level EC numbers of over 229,000 proteins based solely on their predicted structures. Additionally, this capability facilitates the rapid discovery of novel therapeutic targets in neurodegenerative diseases and other complex conditions.
EC-LMGraph utilizes a combination of protein language models and graph convolutional networks. This provides a more refined focus on catalytic sites and functional residues compared to the DeepFRI architecture.
Yes, EC-LMGraph can be combined with AlphaFold2 to predict enzyme functions and sites using high-confidence predicted structures instead of experimental ones.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ng YL et al. Accurate proteome-wide prediction of enzymes and catalytic sites using graph deep learning and protein language model. Gigascience. 2026 May 13. doi: undefined. PMID: 42126889.
Capela J, et al. Comparative Assessment of Protein Large Language Models for Enzyme Commission Number Prediction. BMC Bioinformatics. 2025 Feb 27;26(1):60.
Zhao H, et al. CLEAN: AI Predicts Enzyme Function Better than Leading Tools. Science. 2023 Mar 31;379(6639):1320-1324.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


EC-LMGraph is a graph deep learning tool that accurately predicts enzyme functions and catalytic sites, outperforming existing frameworks like DeepFRI....
5 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A 25-year multi-institutional cohort reveals high recurrence rates in pediatric giant cell tumor of bone, particularly in patients with open physes and bone marrow edema on preoperative MRI. Early surveillance and careful balance between growth plate preservation and tumor clearance are essential.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today